相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oropharyngeal cancers: Relationship between epidermal growth factor receptor alterations and human papillomavirus status
H. Mirghani et al.
EUROPEAN JOURNAL OF CANCER (2014)
Human papilloma virus testing in oropharyngeal squamous cell carcinoma: What the clinician should know
Haitham Mirghani et al.
ORAL ONCOLOGY (2014)
PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma
Simion I. Chiosea et al.
BMC CANCER (2013)
Early-stage squamous cell carcinoma of the oropharynx: Radiotherapy vs. Trans-Oral Robotic Surgery (ORATOR) - study protocol for a randomized phase II trial
Anthony C. Nichols et al.
BMC CANCER (2013)
Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
Sofia Lyford-Pike et al.
CANCER RESEARCH (2013)
Drug of the year: Programmed Death-1 receptor/Programmed Death-1 Ligand-1 receptor monoclonal antibodies
Caroline Robert et al.
EUROPEAN JOURNAL OF CANCER (2013)
Patient preferences for oropharyngeal cancer treatment de-escalation
Drew C. Brotherston et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)
Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia
Wen Yang et al.
IMMUNOLOGY (2013)
Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group
Pierre Blanchard et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Deintensification Candidate Subgroups in Human Papillomavirus-Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis
Brian O'Sullivan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
Jan B. Vermorken et al.
LANCET ONCOLOGY (2013)
Mission impossible: How HPV-associated head and neck cancers escape a primed immune response
Sara I. Pai
ORAL ONCOLOGY (2013)
Identification of clinically relevant HPV-related HNSCC: In p16 should we trust?
Bohdan Wasylyk et al.
ORAL ONCOLOGY (2013)
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
Vivian W. Y. Lui et al.
CANCER DISCOVERY (2013)
High Frequency of Activating PIK3CA Mutations in Human Papillomavirus-Positive Oropharyngeal Cancer
Anthony C. Nichols et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2013)
B7-H1 Expression Model for Immune Evasion in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma
Odey C. Ukpo et al.
HEAD & NECK PATHOLOGY (2013)
mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
Alfredo A. Molinolo et al.
CLINICAL CANCER RESEARCH (2012)
ATYPICAL CLINICAL BEHAVIOR OF p16-CONFIRMED HPV-RELATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA TREATED WITH RADICAL RADIOTHERAPY
Shao Hui Huang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Transoral robotic surgery: A multicenter study to assess feasibility, safety, and surgical margins
Gregory S. Weinstein et al.
LARYNGOSCOPE (2012)
Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation
Brian O'Sullivan et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Robotic Surgery for Oropharynx Cancer: Promise, Challenges, and Future Directions
John R. de Almeida et al.
CURRENT ONCOLOGY REPORTS (2012)
HPV Specific Testing: A Requirement for Oropharyngeal Squamous Cell Carcinoma Patients
Max Robinson et al.
HEAD & NECK PATHOLOGY (2012)
Future Directions in Research, Treatment and Prevention of HPV-Related Squamous Cell Carcinoma of the Head and Neck
Amanda Psyrri et al.
HEAD & NECK PATHOLOGY (2012)
p16 Immunohistochemistry As a Standalone Test for Risk Stratification in Oropharyngeal Squamous Cell Carcinoma
James S. Lewis
HEAD & NECK PATHOLOGY (2012)
Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study
John Farley et al.
GYNECOLOGIC ONCOLOGY (2011)
Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
Alessandro D. Santin et al.
GYNECOLOGIC ONCOLOGY (2011)
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Anil K. Chaturvedi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
Nishant Agrawal et al.
SCIENCE (2011)
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky et al.
SCIENCE (2011)
Oropharyngeal Cancer, Human Papilloma Virus, and Clinical Trials
Danny Rischin
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
Danny Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Current trends in initial management of oropharyngeal cancer: the declining use of open surgery
Missak Haigentz et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2009)
Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C.
David J. Adelstein et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)
Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?
Anders Nasman et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix A Gynecologic Oncology Group Study
Russell J. Schilder et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Jean-Pierre Pignon et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis
Mitchell Machtay et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
Carole Fakhry et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen
Serge J. Smeets et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
Marshall R. Posner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship
Peter C. Levendag et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose-effect relationships for the swallowing structures
Felix Y. Feng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus
SJ Smeets et al.
ONCOGENE (2006)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer
R Hitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?
A Eisbruch et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Efficacy of selective neck dissection: A review of 503 cases of elective and therapeutic treatment of the neck in Squamous cell carcinoma of the upper aerodigestive tract
P Ambrosch et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2001)
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
ML Gillison et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
